Group One Trading, L.P. Cardiff Oncology, Inc. Transaction History

Group One Trading, L.P.

$2.68 Billion
Q2 2025

A detailed history of Group One Trading, L.P. transactions in Cardiff Oncology, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 2,863 shares of CRDF stock, worth $6,269. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,863

Previous 873 227.95%

Holding current value

$6,269

Previous $2,000 350.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$2.38 - $4.3 $4,736 - $8,557	1,990 Added 227.95%	2,863 $9,000
Q1 2025 May 14, 2025	SELL	$3.14 - $4.75 $33,167 - $50,174	-10,563 Reduced 92.37%	873 $2,000
Q4 2024 Feb 14, 2025	SELL	$2.31 - $5.35 $69,664 - $161,345	-30,158 Reduced 72.51%	11,436 $49,000
Q3 2024 Nov 14, 2024	BUY	$2.05 - $2.77 $13,976 - $18,885	6,818 Added 19.61%	41,594 $111,000
Q2 2024 Aug 14, 2024	BUY	$2.22 - $5.89 $54,705 - $145,141	24,642 Added 243.16%	34,776 $77,000
Q1 2024 May 10, 2024	SELL	$1.46 - $5.91 $3,274 - $13,256	-2,243 Reduced 18.12%	10,134 $54,000
Q4 2023 Feb 14, 2024	SELL	$0.96 - $1.55 $20,953 - $33,831	-21,827 Reduced 63.81%	12,377 $18,000
Q3 2023 Nov 09, 2023	BUY	$1.38 - $2.18 $8,594 - $13,577	6,228 Added 22.26%	34,204 $47,000
Q2 2023 Aug 09, 2023	BUY	$1.37 - $1.95 $8,003 - $11,391	5,842 Added 26.39%	27,976 $41,000
Q1 2023 May 12, 2023	BUY	$1.45 - $2.09 $32,094 - $46,260	22,134 New	22,134 $36,000
Q3 2022 Nov 09, 2022	SELL	$1.54 - $3.21 $49,049 - $102,238	-31,850 Reduced 87.33%	4,619 $7,000
Q2 2022 Aug 11, 2022	SELL	$1.17 - $2.61 $8,289 - $18,491	-7,085 Reduced 16.27%	36,469 $80,000
Q1 2022 May 12, 2022	BUY	$2.11 - $7.25 $10,345 - $35,546	4,903 Added 12.69%	43,554 $108,000
Q4 2021 Feb 11, 2022	SELL	$5.18 - $7.24 $174,400 - $243,756	-33,668 Reduced 46.55%	38,651 $232,000
Q3 2021 Nov 12, 2021	BUY	$5.01 - $7.58 $314,106 - $475,235	62,696 Added 651.52%	72,319 $482,000
Q2 2021 Aug 10, 2021	BUY	$6.65 - $10.04 $63,992 - $96,614	9,623 New	9,623 $64,000

Others Institutions Holding CRDF

# of Institutions

126

Shares Held

25.8M

Call Options Held

1.01M

Put Options Held

293K

View Full List

About Cardiff Oncology, Inc.

Ticker CRDF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,334,900
Market Cap $94.9M
Description
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...

More about CRDF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Cardiff Oncology, Inc. Transaction History